Introduction
The multicatalytic proteasome is a highly conserved cellular structure that is responsible for the ATPdependent proteolysis of a large number of cellular proteins. Although the 20S proteasome contains the proteolytic core, it cannot degrade proteins in vivo unless it is complexed with 19S caps, at either end of its structure, which itself contains multiple ATPase activities. This larger structure is known as the 26S proteasome and rapidly degrades proteins that have been targeted for degradation by the addition of multiple molecules of the 8.5 kDa polypeptide ubiquitin.
Inhibitors of the ubiquitin-proteasome pathway have been suggested as novel antitumor agents in cancer therapy Lee and Goldberg, 1998) . Most advanced is PS-341, a highly potent boronate containing proteasome inhibitor currently in phase I clinical evaluation as a cytotoxic agent. Although proteasome inhibitors could act through multiple mechanisms to arrest tumor growth, they are assumed to retard cancer progression by interfering with the regulated and temporally ordered proteolysis of proteins.
Proteins targeted for proteasomal degradation have functions in a wide variety of cellular processes from growth factor response (Bai, 1995) to antigen presentation (Bogyo et al., 1997) , cell cycle control (Machiels et al., 1997) , DNA repair (Schauber et al., 1998) , proliferation (Wang et al., 1998a) and apoptosis (Drexler, 1998) .
Most prominently, the stability of a large number of transcription factors is regulated via ubiquitination (Goodbourn and King, 1997; Kawazoe et al., 1998) . Transcriptional response to stress signals like proteasome inhibitor treatment is a complex process (Palombella et al., 1994; Ichihara and Tanaka, 1995; Firestein and Feuerstein, 1998; Hofmann et al., 1996; Bonvini et al., 1998) with the response of many genes being dependent on crosstalk between signal transduction pathways and cell type speci®c factors.
Proteasome inhibitors induce apoptosis in a broad range of cells independent of p53, Bax, Bad, Bak, Bcl-2 or Bcl-X L (Herrmann et al., 1998) . The contribution of key cell cycle regulatory proteins, like p21 and p27, to proteasome inhibitor-induced cell cycle arrest has been well established Lloyd et al., 1999) .
In particular, human glioma cells respond to proteasome inhibition with programmed cell death (Kitagawa et al., 1999) . Cycloheximide delays this response considerably indicating that de novo synthesis of proteins contributes to the regulation of apoptosis upon proteasome inhibition. Transcription factors in addition to p53 are therefore expected to act as key regulators of the apoptotic process.
We therefore wanted to identify transcription factor encoding genes aected by proteasome inhibition. To elucidate pathways aected by the proteasome leading to upregulation of transcription factors and to induction of apoptosis, gene expression pro®les were generated, comparing changes of mRNA expression of 7900 genes from the UniGene collection (Miller et al., 1997) upon exposure of cells to the proteasome inhibitors Lactacystin, Lactacystin-b-lactone or MG132 by means of microarray based cDNA hybridization (Schena et al., 1996) . binding to and inhibiting the 20S proteasome (ImajohOhmi et al., 1995) . Therefore, gene expression changes associated with Lactacystin treatment were monitored in this cell line by high density microarray based hybridization of 7900 genes. The randomly selected genes were typically represented as approximately 1 kb cDNA fragments. About a third of the 7900 genes represented known genes annotated in GenBank. A further third represented expressed sequence tags with a high degree of homology to known genes and the last third was accrued from expressed sequence tags with unknown function. Fluorescent probes for hybridization were derived from two sources of mRNA ± MCF7 cells treated with DMSO or 10 mM Lactacystin for 21 h ± which were labeled by reverse transcription with two dierent¯uorophores to provide a direct and internally controlled comparison of the mRNA expression level of every gene present on the array. In principle, the technology has been described (Schena et al., 1995; Shalon et al., 1996) . The average standard deviation of the relative¯uorescent signal of individual data points between independent, but identical experiments was below 20%. Therefore twofold changes of expression could be monitored with high con®dence. Table 1 summarizes the induction (a) or repression (b) ratios, respectively, for the genes regulated by Lactacystin. Lactacystin is a prodrug, which is converted to Lactacystin-b-lactone, the proteasome inhibiting moiety and is unstable in aqueous solution and N-acetyl-cysteine. In order to exclude N-acetylcysteine eects which have been implicated in regulating apoptosis (Talley et al., 1995) additional mRNA pro®les of cells treated with Lactacystin-b-lactone, and with MG132, a chemically very dierent, peptidic 20S proteasome inhibitor, were generated. The mRNA representations by all three compounds were at least in qualitative terms very similar (Figure 1a) , con®rming that the gene expression changes were indeed due to proteasome inhibition. Moreover, a fourth mRNA pro®le experiment was done upon treatment of NCI-H1299 cells for 24 h with 1 mM Trapoxin A, a compound that has been previously reported to have an impact on gene expression (Van Lint et al., 1996) . Trapoxin A is a histone deacetylase (HDA) inhibitor from a dierent chemical class, which has been shown to have antitumor activities (Yoshida and Sugita, 1992) . Most of the genes whose expression was in¯uenced by Lactacystin was not in¯uenced by Trapoxin A (Figure 1b) . A small number of genes, though, were induced by Lactacystin, but not by lactacystin-b-lactone or MG132: alpha cristallin and 3 ESTs with unknown function. Tis11d, mss4, integrin beta 4, the HHCPA78 homolog and the HCR gene were exclusively repressed by Lactacystin.
The Lactacystin in¯uenced genes could be grouped according to their functions: (i) Heat shock response genes including members of the HSP40, Hsp70 and Hsp90 family were upregulated, which is in agreement with earlier reports (Bush et al., 1997) ; (ii) A number of enzymes involved in aminoacid and polysaccharide metabolism were also upregulated. This might be due to feedback regulatory mechanisms; (iii) Induction of mRNAs encoding ubiquitin as well as three proteasome subunits (subunit 4, iota, C9) could again be interpreted to constitute some sort of feedback regulation; (iv) The cell cycle kinases Cdk2, Cdk4 and CAK, topoisomerase II and replication factor were suppressed. This, together with the induction of the cell cycle control gene p21/WAF1/CIP1, the stabilization of which was corroborated by Western blot analysis (Figure 2 ) and published previously (Blagosklonny et al., 1996) , explained the induction of cell cycle arrest by Lactacystin at the molecular level; (v) The microtubule associated protein 1b was induced whereas tubulin 1b was repressed; (vi) Genes involved in growth factor response were found to be repressed: insulin like growth factor binding proteins 4 and 5; (vii) To us most intriguing, many mRNAs encoding transcription regulators were in¯uenced. In particular, GATA-3 and CA150 were repressed, whereas the C/EBP family members Gadd153 and ATF3 were strongly induced. The two proteins Gadd153 and ATF3 heterodimerize to regulate the expression of a large number of cAMP response genes in either a positive or negative manner (Chen et al., 1996a; Fawcett et al., 1996) . In this study, the induction and/or stabilization of both was con®rmed at the mRNA level by real-time reverse transcriptase PCR (Table 2) and at the protein level by Western blotting (Figure 2 ). The induction was dose dependent and fast. Gadd153 and ATF3 mRNA levels after MG132 treatment started to increase after 2 h and peaked between 12 and 16 h. A similar Gadd153 and ATF3 induction pro®le was observed in the p53 negative myoblastic cell line M1 and in the p53 mutant breast carcinoma cell line MDA-MB 435 (not shown), con®rming that the inductions were neither cell type nor p53 dependent. In contrast, Trapoxin A did not induce Gadd153 and ATF3 in MCF7 cells (Figure 3 ), supporting the notion that the induction was a consequence of proteasome inhibition and not indirectly due to cell cycle arrest and apoptosis.
The mRNA encoding a third transcription regulator, MAD1, was signi®cantly (more than twofold) upregulated: 3.9-fold with Lactacystin, twofold with MG132, 2.5-fold with Lactacystin-b-lactone and twofold with the histone deacetylase inhibitor Trapoxin A. As MAD1 induction is lower than ®vefold with any proteasome inhibitor, it is not included in Table 1 or Figure 1 . Overexpression of MAD1 after 14 h treatment with MG132 was con®rmed by Western blotting (Figure 2 ). In contrast to p21 and ATF3 protein levels that appeared to be induced already after 3.5 h proteasome inhibitor treatment, marked enhanced Mad1 protein levels were only seen after 14 h incubation.
Discussion
Since the initial development of cDNA microarray hybridization (Schena et al., 1995) , there has been considerable interest in this rapidly emerging technology. The ability to compare relative levels of thousands of mRNA transcripts simultaneously in a single hybridization experiment has the potential to contribute signi®cantly to our understanding of cellular pathways at the molecular level. However, the results of microarray gene expression pro®les must be assessed carefully. The stability of mRNA and of its gene product, the translation eciency and proteolytic degradation greatly contribute to the apparent intra- The gene # given in the third column referred to the graphical representation of induced and repressed clones in Figure 1 . Clones regulated more than ®vefold with either Lactacystin, Lactacystin-b-lactone or MG132 were listed. Based on standard error analysis of chip based hybridization experiments, a twofold regulation was determined to be statistically signi®cant cellular protein level and to the biological signi®cance of the gene regulation. In addition, the regulation of poorly expressed genes might be overestimated on the cDNA microarray chips. Development of the quantitative real-time RT ± PCR method for the determination of relative changes in gene expression oers the added advantage of expanding this approach beyond simple pair-wise comparisons (Heid et al., 1996) . The application of cDNA array hybridization as a high-throughput screening method for dierential gene expression has been applied to develop a more comprehensive picture of pathways associated with genotoxic stress (Amundson et al., 1999) and to characterize transformation related genes in oral cancer cells (Chang et al., 1998) and in ®broblasts (Tchernitsa et al., 1999) .
We have used a similar approach to study the complex consequences of proteasome inhibition in the human breast carcinoma cell line MCF7. The approach chosen did point towards a large number of pathways aected by the proteasome. In the present study, we focused on transcriptional regulators as early, time-and dosedependently upregulated proteins that point to key decisions in cellular pathways. The mechanism underlying the gene expression of transcription regulators was expected to be a direct one, via stabilization of existing or de novo synthesis of mRNA, rather than an indirect consequence of the induction of cell cycle arrest and/or (0), 0.5 and 5 mM MG132 or 0.5 and 5 mM Trapoxin A, respectively. Forty mg of cell lysates were analysed by immunoblotting for Gadd153 and ATF3 expression The mRNA levels were determined using the comparative G T method (PE user bulletin ABI PRISM 7700, 1997) apoptosis. In contrast to upregulation of many heat shock proteins and other proteins involved in the regulation of the cell cycle (e.g. p21), transcription regulators were not yet known to be upregulated at the mRNA level upon proteasome inhibition. We focused on the three upregulated transcriptional regulators Gadd153, ATF3 and Mad1 for detailed analysis. Two hours after addition of MG132, a speci®c and signi®cant increase in ATF3 and Gadd153 gene expression at the mRNA level was measured by real-time RT ± PCR (Table 2) con®rming an early and rapid stress response by transcriptional regulators. Both, Gadd153, also known as CHOP-10 or Ddit3, and the activating transcription factor ATF3 are transcription factors of the CCAAT/enhancer binding protein (C/EBP) family (Fawcett et al., 1999) . Gadd153 is a small nuclear protein that dimerizes avidly with other members of the C/EBP family. Normally undetectable at the protein level, it is expressed at high levels in cells exposed to conditions that perturb protein folding in the endoplasmatic reticulum and induce an endoplasmatic reticulum stress response Outinen et al., 1998) . Gadd153 expression in stressed cells is linked to the development of programmed cell death (Masumoto et al., 1996; Eymin et al., 1997) and, in some instances, cellular regeneration (Zinszner et al., 1998) .
The stress-inducible transcription factor ATF3 is interacting with and modulated by Gadd153 (Chen et al., 1996a) , forming a heterodimer that, in contrast to the ATF3 homodimer, does not bind to the ATF/cyclic AMP response element consensus site and does not repress transcription. Inversely, ATF3 function is inhibited by Gadd153 (Wolfgang et al., 1997) . Despite the overwhelming evidence for the induction of ATF3 by stress signals, not much else is known about ATF3. Transient transfection and in vitro transcription assays indicate that ATF3 represses transcription as a homodimer; however, ATF3 can activate transcription when coexpressed with heterodimeric partners such as Gadd153 or other proteins. It is therefore possible that, when induced during proteasome inhibition, ATF3 as a stress-mediating factor activates some target genes but represses others, depending on promotor context. The third transcription regulator analysed in this context, Mad1, was induced with very much delayed kinetics. Mad1 is a basic helix ± loop ± helix-leucine zipper (bHLH-Zip) transcriptional repressor protein that is induced upon cell dierentiation and inhibits proliferation by blocking cell cycle progression at G1 transition as shown in 3T3 cells (Roussel et al., 1996) . Mad1 dimerizes with Max and binds to the same DNA sequences as Myc : Max dimers do, but antagonizes Myc (Ayer et al., 1993) . Based on our microarray cDNA hybridization experiments with proteasome inhibitors, Myc itself is not upregulated on the mRNA level (not shown). Mad1 has been shown to block the oncogenic activity of Myc. Myc : Max heterodimers activate transcription of particular promotors while Mad : Max heterodimers repress transcription. More recently, Mad1 expression in primary gastric cells was shown to inhibit proliferation and to be inversely correlated with Myc protein expression (Han et al., 1999) .
From the much delayed kinetics of Mad1 induction it could be interpreted that the Mad1 response represents a secondary eect, linked to cell cycle arrest or even apoptosis, rather than proteasome inhibition. Moreover, Trapoxin A also induced Mad1 to a lesser extent, supporting the above interpretation. However, a more direct, mechanistic connection between the leucine zipper proteins Mad1, ATF3 and Gadd153 cannot be excluded since Myc : Max heterodimers inhibit Gadd153 expression (Chen et al., 1996b; Amundson et al., 1998) and in all probability activate ATF3 (Liang et al., 1996) .
Materials and methods

Cell culture
The human breast cancer cell line MCF7 was obtained from American Tissue Culture Collections (ATCC number HTB-22) (Giard et al., 1973; Cailleau et al., 1974) . MCF7 cells were cultured at 378C in a 5.5% CO 2 atmosphere in Minimum Essential Medium alpha with ribonucleosides and deoxyribonucleosides, supplemented with 10% fetal calf serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids and 0.01 mg/ml gentamycin (Gibco ± BRL, Life Technologies AG, Basel, Switerland). Subcon¯uent cells were treated with proteasome inhibitors ZLeu-Leu-Leu-CHO (MG132), Lactacystin and Lactacystin-blactone (AFFINITI Research Products Ltd, Mamhead Castle, UK) for indicated times and doses. The human non-small cell lung cancer cell line NCI-H1299 was obtained from American Tissue Culture Collections (ATCC number CRL-5803) and cultured in RPMI 1640 medium containing 10% fetal calf serum in a 5.5% CO 2 atmosphere at 378C. One mM Trapoxin A was added to exponentially growing NCI-H1299 cells for the indicated time and dose.
RNA isolation
For total RNA isolation, MCF7 cells at a density of 1610 5 cells per ml were harvested by centrifugation and homogenized in 1 ml denaturing solution per 10 7 cells (4 M guanidine thiocyanate, 25 mM sodium citrate, 0.5% sarcosyl, 0.1 M b-mercaptoethanol) by passing the lysate through a pipet 20 times. In a 5 ml polypropylene tube the homogenate was mixed sequentially with 0.1 volume 2 M sodium acetate (pH 4), one volume water saturated phenol and 0.2 volume chloroform/isoamyl alcohol (49 : 1). After incubation on ice for 15 min the mixture was centrifuged for 20 min at 10 000 g, yielding an upper aqueous phase containing total RNA. The RNA was precipitated by adding 1 ml (1 vol) of 100% isopropanol and recovered by centrifugation for 10 min at 4000 r.p.m., 48C. The RNA pellet was dissolved in 0.3 ml denaturing solution and transferred to a 1.5 ml microcentrifuge tube. The RNA was reprecipitated with 0.3 ml of 100% isopropanol (one volume) and stored at 7208C until use. The RNA was recovered by centrifugation for 10 min at 10 000 g, 48C, and the RNA pellet was resuspended in 75% ethanol/water, vortexed, and incubated for 10 ± 15 min at room temperature to dissolve residual amounts of guanidinium contaminating the pellet. After centrifugation for 5 min at 10 000 g the RNA pellet was dissolved in 100 ± 400 ml DEPC-treated water and quantitated. Samples were stored frozen at 7708C.
Poly(A) + -RNA was isolated from 250 mg total RNA with the Oligotex m-RNA mini kit (Qiagen, Hilden, Germany) as described in the manufacturer's protocol. The RNA was ®nally eluted twice with 20 ml elution buer using the ®rst eluate again for the second elution.
cDNA array hybridization
The probes used for the UniGEM hybridization were synthesized with the GEMbright cDNA synthesis kit from Incyte Inc. (Palo Alto, CA, USA). Single stranded probe synthesis was started from 200 ng poly(A) + -RNA from DMSO mock-treated and compound-treated MCF7 cells. The following compounds supplied with the kit were added as a master mix of 15 ml to the RNA adjusted to 5 ml volume; 5 ml 56-buer, 5 ml water, 1 ml RNase-inhibitor, 3 ml Cy3 or Cy5 labeling mix, and 1 ml reverse transcriptase. cDNA synthesis was performed at 378C for 2 h. The RNA was degraded by adding 2.5 ml 0.5 M NaHCO 3 pH 9.2 and incubated at 858C for 20 min. The samples were diluted with 15 ml water and puri®ed over two consecutive Chromaspin 30+TE columns (Clontech, Palo Alto, CA) according to the manufacturer's recommendations. The eluted probes were dried in a speedvac to complete dryness and shipped to Incyte Inc. for hybridization. As far as possible probes were protected from light throughout the process.
Real-time reverse transcription-polymerase chain reaction (realtime RT ± PCR)
The PCR-primers and TaqMan probes to amplify and detect GADD153 and ATF3 m-RNA were designed using the Primer Express software version 1.0 (Perkin Elmer/Applied Biosystems, Foster City, USA) based on the sequences reported in GenBank (Paul et al., 1990) as follows: GADD153 forward primer 5'-GGAGAACCAGGAAACG-GAAAC; GADD153 reverse primer 5'-TCTCCTTCA-TGCGCTGCTTT; GADD153 probe FAM/TAMRA 5'-AGTGGTCATTCCCCAGCCCGG; ATF3 forward primer 5'-TGCCTCGGAAGTGAGTGCTT; ATF3 reverse primer 5'-GCAAAATCCTCAAACACCAGTG; ATF3 probe FAM/ TAMRA 5'-TGCCATCGTCCCCTGCCTGTC. The PCR primers were purchased from BIG Biotech (Freiburg, Germany). The TaqMan probes were labeled with 6-carboxy-¯uorescein (FAM) as the reporter dye and 6-carboxy-tetramethyl-rhodamine (TAMRA) as the quencher uorescent (Perkin Elmer/Applied Biosystems, Weiterstadt, Germany). A TaqMan-GAPDH control was used to amplify and detect GAPDH as control recommended by the manufacturer (Perkin Elmer/Applied Biosystems): GAPDH forward primer 5'-GCACCGTCAAGGCTGAGAAC; GAPDH reverse primer 5'-GAGGGATCTCGCTCCTGGA; GAPDH probe FAM/TAMRA 5'-CTTGTCATCAATG-GAAATCCCATCACCATC. For real-time RT ± PCR a RNA concentration of 5 ng per reaction was used and a one step, two enzyme system was chosen according to recommendations of the manufacturer, composed of TaqMan PCR Core Reagent Kit, reverse transcriptase MuLV and RNase inhibitor (all Perkin Elmer/Applied Biosystems). Thermal cycling conditions included a RT step (488C, 30 min), followed by Ampli Taq Gold activation (958C, 10 min) and a PCR step of 40 cycles (958C, 15 s/608C, 1 min). Accumulation of PCR products was detected in real time directly by monitoring the probe cleavage induced increase in¯uorescence of the reporter dye with the ABI PRISM 7700 Sequence Detector. Relative quantitation was performed using the comparative C T method as described by the manufacturer (PE user bulletin #2, 1997).
Western blot analysis
Cells were washed twice with PBS (Gibco ± BRL, Life Technologies AG, Basel, Switzerland), lysed with M-PER (Pierce, Rockford, IL, USA) and boiled for 5 min. The protein concentration was normalized by determining the total protein amount in the supernatant using the BCA protein assay kit (Pierce, Rockford, IL, USA). Forty ng of total protein per lane was separated by electrophoresis in 1.5 mm thick SDS-polyacrylamide gels (Bio-Rad, Hercules, CA, USA) and transferred to Protran nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany). All primary antibodies and secondary horseradish peroxidase-conjugated antibodies were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Proteins were detected by chemoluminescence with SuperSignal substrate (Pierce, Rockford, IL, USA).
